Loading...
Walgreens Boots Alliance, Inc.
WBA•NASDAQ
Healthcare
Medical - Pharmaceuticals
$11.61
$0.02(0.17%)
Walgreens Boots Alliance, Inc. (WBA) Financial Performance & Income Statement Overview
Review Walgreens Boots Alliance, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
6.17%
↑ 6.17%
Operating Income Growth
-104.53%
↓ 104.53%
Net Income Growth
-180.39%
↓ 180.39%
Operating Cash Flow Growth
-54.92%
↓ 54.92%
Operating Margin
-2.02%
↓ 2.02%
Gross Margin
17.13%
↑ 17.13%
Net Profit Margin
-4.07%
↓ 4.07%
ROE
-70.17%
↓ 70.17%
ROIC
-7.17%
↓ 7.17%
Walgreens Boots Alliance, Inc. (WBA) Income Statement & Financial Overview
Review Walgreens Boots Alliance, Inc.'s (WBA) income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $38.59B | $39.46B | $37.55B | $36.35B |
| Cost of Revenue | $31.65B | $32.68B | $31.29B | $29.89B |
| Gross Profit | $6.93B | $6.78B | $6.25B | $6.46B |
| Gross Profit Ratio | $0.18 | $0.17 | $0.17 | $0.18 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $8.89B | $7.01B | $6.95B | $6.39B |
| Operating Expenses | $12.50B | $7.02B | $7.23B | $6.35B |
| Total Costs & Expenses | $40.54B | $39.70B | $38.52B | $36.24B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $129.00M | $122.00M | $131.00M | $113.00M |
| Depreciation & Amortization | $611.00M | $625.00M | $622.00M | $607.00M |
| EBITDA | -$3.51B | -$236.00M | -$245.00M | $971.00M |
| EBITDA Ratio | -$0.09 | -$0.006 | -$0.007 | $0.03 |
| Operating Income | -$1.96B | -$236.00M | -$977.00M | $111.00M |
| Operating Income Ratio | -$0.05 | -$0.006 | -$0.03 | $0.003 |
| Other Income/Expenses (Net) | -$2.29B | -$179.00M | -$21.00M | $140.00M |
| Income Before Tax | -$4.25B | -$415.00M | -$998.00M | $251.00M |
| Income Before Tax Ratio | -$0.11 | -$0.01 | -$0.03 | $0.007 |
| Income Tax Expense | -$212.00M | $66.00M | $2.08B | $20.00M |
| Net Income | -$2.85B | -$265.00M | -$3.005B | $344.00M |
| Net Income Ratio | -$0.07 | -$0.007 | -$0.08 | $0.009 |
| EPS | -$3.30 | -$0.31 | -$3.48 | $0.40 |
| Diluted EPS | -$3.30 | -$0.31 | -$3.48 | $0.40 |
| Weighted Avg Shares Outstanding | $864.10M | $863.80M | $863.70M | $863.10M |
| Weighted Avg Shares Outstanding (Diluted) | $864.10M | $863.80M | $863.70M | $864.30M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan